Development of a sandwich enzyme-linked immunosorbent assay for the quantification of ponatinib in serum

Yuta Yamamoto, Tetsuya Saita, Rintaro Sogawa, +6

Analytical Biochemistry

AllergyMedicineBioanalysisImmunologySerologic Testing +2

An ultra-specific and sensitive sandwich ELISA for imatinib using two anti-imatinib antibodies

Tetsuya Saita, Yuta Yamamoto, Kazuhisa Hosoya, +4

Analytica Chimica Acta

Molecular Diagnostic TechniquesImmunocytochemical TechniqueAllergyMedicineBioanalysis +10

Development of a competitive enzyme-linked immunosorbent assay for therapeutic drug monitoring of afatinib

Rintaro Sogawa, Tetsuya Saita, Yuta Yamamoto, +4

Journal of Pharmaceutical Analysis

Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL

Yuki Kurahashi, Tatsuro Watanabe, Yuta Yamamoto, +11

Blood Advances

Histone ModificationsMixed-phenotype Acute LeukemiaEpigenetic ChangeDna MethylationImmunology +18

Targeting DNMT1 by demethylating agent OR-2100 increases tyrosine kinase inhibitors-sensitivity and depletes leukemic stem cells in chronic myeloid leukemia

Kazuharu Kamachi, Hiroshi Ureshino, Tatsuro Watanabe, +10

Cancer Letters

Mixed-phenotype Acute LeukemiaLow Tkis SensitivityTumor BiologyMyeloid NeoplasiaHematological Malignancy +14

Adult T‐cell leukemia‐lymphoma acquires resistance to <scp>DNA</scp> demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism

Nao Yoshida‐Sakai, Tatsuro Watanabe, Yuta Yamamoto, +5

International Journal of Cancer

Quantitative determination of erlotinib in human serum using competitive enzyme-linked immunosorbent assay

Yuta Yamamoto, Tetsuya Saita, Y. Lucas Yamamoto, +1

Journal of Pharmaceutical Analysis

Silylation of Deoxynucleotide Analog Yields an Orally Available Drug with Antileukemia Effects

Hiroshi Ureshino, Yuki Kurahashi, Tatsuro Watanabe, +13

Molecular Cancer Therapeutics

Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia

Kazuharu Kamachi, Hiroshi Ureshino, Tatsuro Watanabe, +7

Cancer Research Communications